TickerFactsScreenerDevelopers

Viking Therapeutics, Inc. (VKTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$14.76M2018: -$18.75M2019: -$24.75M2020: -$21.78M2021: -$47.59M2022: -$48.40M2023: -$73.38M2024: -$87.79M2025: -$278.69M-$278.69M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$278.69M-217.4%
2024-$87.79M-19.6%
2023-$73.38M-51.6%
2022-$48.40M-1.7%
2021-$47.59M-118.5%
2020-$21.78M+12.0%
2019-$24.75M-32.0%
2018-$18.75M-27.1%
2017-$14.76M—